A mitochondrial based oncology platform for targeting cancer stem cells (CSCs): MITO-ONC-RX. [electronic resource]
- Cell cycle (Georgetown, Tex.) 2018
- 2091-2100 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review